CompletedNCT05792540
Dapagliflozin and atorvastatin study in major depression
About this title
Read the official source — NCT05792540Medication studyAges 18–75Egypt
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- TantaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: June 6, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- Tanta University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Egypt
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05792540
- Official title
Show the full official title
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tanta University, a university.
Did this study involve medication?
Yes. The study involved medication, including Fluoxetine 20 mg, Dapagliflozin 10mg Tab and Atorvastatin 80mg.
Who was this study for?
Listed age limits: 18 years to 75 years.
